Results 221 to 230 of about 52,946 (303)

Prescription of Opioid Analgesics for Chronic Non-Cancer Pain in Germany despite Contraindications: Administrative Claims Data Analysis. [PDF]

open access: yesInt J Environ Res Public Health
Niemann A   +11 more
europepmc   +1 more source

Gender and Overdose Risk Factors Among Clients Entering Residential Treatment for Opioid Use

open access: yesDrug and Alcohol Review, EarlyView.
ABSTRACT Introduction The period post‐residential treatment for opioid use is associated with heightened risk of overdose. The current study aims to: (i) describe characteristics of men and women attending residential treatment for primary opioid use; (ii) identify classes of clients based on primary opioid and other substance/s of concern and (iii ...
Chloe J. Haynes   +9 more
wiley   +1 more source

Proper use of opioid analgesic

open access: bronze, 2006
Tsutomu Suzuki   +4 more
openalex   +2 more sources

Comparison of Remimazolam and Propofol for Sedation in Endoscopic Retrograde Cholangiopancreatography: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis

open access: yesDigestive Endoscopy, EarlyView.
This systematic review and meta‐analysis of 5 randomized controlled trials (n = 965) compares the safety profile of remimazolam versus propofol for sedation during ERCP. Remimazolam was associated with a significantly lower incidence of hypoxia, hypotension, and bradycardia.
In Jung Kim   +3 more
wiley   +1 more source

Feasibility, safety and efficacy of intranasal fentanyl in the treatment of acute pain episodes among adults with sickle cell disease: A retrospective single‐centre study

open access: yes
British Journal of Haematology, EarlyView.
Lauren Arena   +8 more
wiley   +1 more source

Illustrating stories of stigma from the perspective of people living with diabetes while experiencing homelessness: An arts‐based community participatory research project

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Our objective was to explore the stigma experienced by people with lived experiences of both diabetes and homelessness. Methods This community‐based participatory research (CBPR) project was underpinned by a partnership between academic researchers and those with lived experience (co‐researchers).
Saania Tariq   +10 more
wiley   +1 more source

Evaluating biased agonism of glucagon‐like peptide‐1 (GLP‐1) receptors to improve cellular bioenergetics: A systematic review

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are highly effective antidiabetic and anti‐obesity agents. Recent development and optimisation of these agents includes biased agonism (selective activation of a downstream signalling pathway) of the GLP‐1 receptor, which has demonstrated greater weight‐lowering effects and improved insulin
Sabrina Wong   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy